Sort   by:  
 Page size 
UnknownLower vitamin D is associated with metabolic syndrome and insulin resistance in systemic lupus: data from an international inception cohort.
Not available
S-EPMC8487307 | biostudies-literature
TranscriptomicsHuman Whole Blood: Psoriatic Arthritis [PsA] vs. Cutaneous Psoriasis Without Arthritis [PsC] vs. Controls
Transcriptional profiling of human whole blood comparing PsA, PsC, and unaffected controls Three condition experiment: PsA, PsC, unaffected controls. Biological replicates: 20 PsA, 20 PsC, 12 controls
ORGANISM(S): Homo sapiens 
2014-09-24 | E-GEOD-61281 | biostudies-arrayexpress
UnknownCombining Clinical, Genetic and Protein Markers Using Machine Learning Models Discriminates Psoriatic Arthritis Patients From Those With Psoriasis.
Not available
S-EPMC12089127 | biostudies-literature
UnknownClinical, laboratory and health-related quality of life correlates of Systemic Lupus Erythematosus Responder Index response: a post hoc analysis of the phase 3 belimumab trials.
Not available
S-EPMC4225741 | biostudies-literature
UnknownSorghum MSD3 Encodes an ω-3 Fatty Acid Desaturase that Increases Grain Number by Reducing Jasmonic Acid Levels.
Not available
S-EPMC6862555 | biostudies-literature
UnknownEvaluating antibiosis resistance to cabbage aphid (Brevicoryne brassicae L., 1758) in vegetable brassicas (Brassica oleracea L.) and related C-genome brassica species.
Not available
S-EPMC12618919 | biostudies-literature
UnknownEarly and sustained efficacy with apremilast monotherapy in biological-naive patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE).
Not available
S-EPMC5909747 | biostudies-literature
UnknownImprovements in productivity at paid work and within the household, and increased participation in daily activities after 24 weeks of certolizumab pegol treatment of patients with psoriatic arthritis: results of a phase 3 double-blind randomised placebo-controlled study.
Not available
S-EPMC4283690 | biostudies-literature
UnknownIdentification of distinct disease activity trajectories in patients with psoriatic arthritis receiving tofacitinib: a post hoc analysis of two phase 3 studies
Not available
S-EPMC12142151 | biostudies-literature
UnknownEffect of certolizumab pegol on multiple facets of psoriatic arthritis as reported by patients: 24-week patient-reported outcome results of a phase III, multicenter study.
Not available
S-EPMC4171746 | biostudies-literature
Sort   by:  
 Page size